Bobby Nibhanupudy
Transplant Surgery · Orlando, FLNPI 1407956725
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,266 of the $2,924 with a category attached, or 77.5%. 22 manufacturers reported payments, led by Xvivo Perfusion Inc. at 31.9% of the total. Reporting peaked in 2024 at $1,022 and has fallen 69.1% since, to $316 in 2025. That places this record below the midpoint for transplant surgery clinicians in FL, where the typical reported total is $3,023.
Across 70 payments — averaging $41.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Xvivo Perfusion Inc.$934
- AstraZeneca$344
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$325
- Veloxis Pharmaceuticals, Inc.$230
- Intercept Pharmaceuticals, Inc.$179
- AbbVie$125
- plus $787 from 16 others
Across 4 payments — averaging $1266.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shire North American Group Inc$3K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
What the payments were for
- Travel & lodging$47916%
- Food & beverage$2,26677%
- Education$1796%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Xvivo Perfusion Inc. | 2 | $934 |
| AstraZeneca(2 entities) | 8 | $344 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $325 |
| Veloxis Pharmaceuticals, Inc. | 6 | $230 |
| Intercept Pharmaceuticals, Inc. | 9 | $179 |
| AbbVie | 1 | $125 |
| Johnson & Johnson | 4 | $106 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $105 |
| Shionogi Inc | 4 | $92 |
| Integra Lifesciences Corporation | 3 | $91 |
| Novartis | 1 | $58 |
| Merck | 3 | $56 |
| Dynavax Technologies Corporation | 2 | $55 |
| Gilead | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Kamada Ltd. | 1 | $34 |
| Novo Nordisk | 1 | $25 |
| Organox Ltd | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $15 |
| Intra-sana Laboratories | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XVIVO Perfusion System (XPS)$934
- LOKELMA$250
- Envarsus$248
- EMBLAVEO$125
- Xerava$105
How this compares
$2,924 in reported general payments places this provider in the 45th percentile of 53 transplant surgery providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 14 | $299,412 |
| Valganciclovir Hcl | 153 | $20,817 |
| Clotrimazole | 125 | $4,379 |
| Ursodiol | 48 | $2,679 |
| Tacrolimus | 20 | $2,284 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 14 | $2,210 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 209 | $1,391 |
| Famotidine | 153 | $1,299 |
| Sure Comfort Pen NeedlePen Needle, Diabetic | 20 | $1,078 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,040 |
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 17 | $964 |
| Nystatin | 17 | $565 |
| Pantoprazole Sodium | 103 | $461 |
| Dapsone | 50 | $398 |
| Prednisone | 60 | $349 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Orlando
- Scott SilvestryOrlando$661K
- Lawrence ChinOrlando$12K
- Michael AngelisOrlando$2K
- Amy LuTampa$133K
- Eduardo AlsinaTampa$121K
- Kiran DhanireddyTampa$40K
- Vijay SubramanianTampa$22K
- Alfred TectorMiami$19K
- Nicole LooJacksonville$17K
- Wen XiePensacola$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.